Results 231 to 240 of about 134,137 (295)

Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Subgroup Analyses of Post‐Marketing Surveillance Data by Age, Prior Chemotherapy Regimen, and Best Overall Response to Prior Chemotherapy

open access: yesCancer Medicine, Volume 14, Issue 21, November 2025.
ABSTRACT Introduction Avelumab maintenance therapy was approved in Japan for curatively unresectable urothelial carcinoma (UC) without progression after prior platinum‐based chemotherapy (PBC) based on results from the JAVELIN Bladder 100 phase 3 trial.
Masayoshi Nagata   +7 more
wiley   +1 more source

A comparative review of myocarditis in pediatrics versus adults: pathogenesis, diagnosis, and management. [PDF]

open access: yesFront Immunol
Ricci JC   +9 more
europepmc   +1 more source

Novel Free-breathing 3D Whole-heart Joint T1/T2 Mapping for the Diagnosis of Myocarditis

open access: gold
Alina Hua   +10 more
openalex   +1 more source

An Unusual Mid‐Ventricular Takotsubo Cardiomyopathy: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT Takotsubo cardiomyopathy (TTC), also known as stress cardiomyopathy, is characterized by transient regional wall motion abnormalities that mimic acute coronary syndrome (ACS) but without obstructive coronary artery disease. Among its various forms, the mid‐ventricular variant is uncommon and diagnostically challenging.
Ibrahim Antoun   +4 more
wiley   +1 more source

Unmasking Idiopathic Inflammatory Myopathy: A Case of Proximal Weakness in a Young Male With Co‐Occurring Vitamin D Deficiency

open access: yesClinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT Idiopathic inflammatory myopathy (IIM) encompasses rare autoimmune disorders causing muscle inflammation and weakness, with subtypes including dermatomyositis, necrotizing myopathy, antisynthetase syndrome, and inclusion body myositis. This case report details a 25‐year‐old South Asian male presenting with a 60‐day history of progressive ...
Ibrahim Khalil   +3 more
wiley   +1 more source

A tour of leukemia progress in 2025, viewed through the MD Anderson leukemia research lens

open access: yesCancer, Volume 131, Issue 21, 1 November 2025.
ABSTRACT Advances in the prognostication, monitoring, and treatment of both the acute and chronic leukemias have led to drastically improved outcomes over the past 2 decades. With the advent of targeted therapies, including antibodies such as blinatumomab and inotuzumab and small molecule inhibitors, such as the BCR::ABL1 tyrosine kinase inhibitors ...
Hagop M. Kantarjian   +13 more
wiley   +1 more source

Clinical application of single‐cell RNA sequencing in disease and therapy

open access: yesClinical and Translational Medicine, Volume 15, Issue 11, November 2025.
This review provides a comprehensive overview of the application of scRNA‐seq in revisiting the somatic cell evolutions in human diseases, as well as in biomarker discovery and drug development. Abstract Background The emergence of single‐cell RNA sequencing (scRNA‐seq) technology has revolutionized our capacity to study cell functions in complex ...
Aisha Shigna Nadukkandy   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy